NCT00324376View on ClinicalTrials.gov

Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

May 31, 2004

Conditions
Chronic Kidney Disease
Interventions
DRUG

Sevelamer hydrochloride

Trial Locations (2)

Unknown

Renal Care Group, Olympia Fields

Kidney and Hypertension Center, Cincinnati

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00324376 - Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer Dosing | Biotech Hunter | Biotech Hunter